Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Yang, Jianmin  [Clear All Filters]
2023
Wang T, Liu P, Xu L, Gao L, Ni X, Tang G, Chen L, Chen J, Wang L, Wang Y, et al. CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-match. Ann Hematol. 2023.
Li X, Liu S, Han S, Sun Q, Yang J, Zhang Y, Jiang Y, Wang X, Li Q, Wang J. Dynamic Stiffening Hydrogel with Instructive Stiffening Timing Modulates Stem Cell Fate in Vitro and Enhances Bone Remodeling in Vivo. Adv Healthc Mater. 2023:e2300326.
Fu W, Huang A, Luo Y, Liu M, Tang G, Yang J, Ni X. Sequential autologous and allogeneic stem cell transplantation for treatment of primary plasma cell leukemia: A case report. Mol Clin Oncol. 2023;19(3):75.
2022
Liu W, Ji J, Zou D, Cao Y, Xu Y, Zhou J, Gao S, Wang F, Chen W, Du J, et al. Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China. Bone Marrow Transplant. 2022.
Li R, Wang Z, Zhang Y, Guo M, Ni X, Chen J, Chen L, Gao L, Gong S, Tang G, et al. Cytogenetic evolution predicts a poor prognosis in acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2022.
2020
Huang A, Zhao X, Li M, Tang G, Fei Y, Wang R, Gao L, Ni X, Zhang W, Yang J, et al. Suppression of hematopoietic primitive cells in patients with secondary failure of platelet recovery after acute graft versus host disease. Biol Blood Marrow Transplant. 2020.
2019
Wang Z, Guo M, Zhang Y, Xu S, Cheng H, Wu J, Zhang W, Hu X, Yang J, Wang J, et al. The applicability of multiparameter flow cytometry for the detection of minimal residual disease using different-from-normal panels to predict relapse in patients with acute myeloid leukemia after allogeneic transplantation. Int J Lab Hematol. 2019.
Yang J, Yang Y, Kawazoe N, Chen G. Encapsulation of individual living cells with enzyme responsive polymer nanoshell. Biomaterials. 2019;197:317-326.
Zhang Y, Gu H, Chen Q, Zhang Y, Cheng H, Yang J, Wang J, Hu X. Low Platelet Counts at Diagnosis Predict Better Survival for Patients with Intermediate-Risk Acute Myeloid Leukemia. Acta Haematol. 2019:1-10.